
BP, ADNOC offer to buy 50% of Israel's NewMed Energy
By Ron Bousso LONDON (Reuters) - BP (LON:BP) and Abu Dhabi's state oil giant on Tuesday offered to jointly acquire 50% of Israeli offshore natural gas producer NewMed Energy for around $2...
|
|
Name
|
Last
|
High
|
Low
|
Chg%
|
Chg
|
Time
|
---|---|---|---|---|---|---|---|---|
Tallinn SE General | 1,862.72 | 1,864.09 | 1,860.17 | +0.17% | +3.20 |
By Ron Bousso LONDON (Reuters) - BP (LON:BP) and Abu Dhabi's state oil giant on Tuesday offered to jointly acquire 50% of Israeli offshore natural gas producer NewMed Energy for around $2...
By Sam Boughedda Bernstein analysts told investors in a note Tuesday that artificial intelligence (AI) will find its place in the restaurants ecosystem, favoring companies such as Yum!...
By Scott Kanowsky Investing.com -- Shares in Oscar Health Inc (NYSE:OSCR) climbed by more than 63% on Tuesday after the U.S.-based health insurance company named former Aetna chairman...
By Sam Boughedda Harmony Biosciences (NASDAQ:HRMY) plunged Tuesday after Scorpion Capital revealed it is short the stock, claiming it is a "house of cards, built on an extensive scientific,...
By Shubham Batra and Amruta Khandekar (Reuters) - The S&P 500 index slipped on Tuesday after a three-day rally fueled by support measures for the banking sector and a deal for Silicon...
Forecasts that relative underperformers in the equities space are poised for a turnaround are a hardy perennial. Still, the expected change always seems to be postponed for several of the...
SHANGHAI/BEIJING (Reuters) -Chinese electric vehicle giant BYD Co Ltd reported an 11-fold increase in fourth-quarter profit as it extended its lead in the domestic market with a wide range...
By Sam Boughedda In a deep dive looking at Apple's (NASDAQ:AAPL) traffic acquisition costs (TAC) and advertising segment, Barclays analysts told investors there are "some risks, but also...
By Senad Karaahmetovic Canaccord Genuity analysts initiated research coverage on Ulta Beauty (NASDAQ:ULTA) with a Buy rating and a $622 per share price target, which implies an upside...
By Senad Karaahmetovic Raymond James analysts upgraded shares of Ciena (NYSE:CIEN) to Strong Buy from Outperform with the price target raised to $70 per share from the prior $58. The...